Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized double-blind placebo-controlled study of HL-1186 tablets in postoperative acute moderate to severe pain
CTR20253086Phase 2Completed
- Sponsor
- Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in postoperative pain comparing HL-1186 with Placebo (2 arms). Started Aug 2025; status: completed.
02
Drugs
HL-1186
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20253086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253086.